Timothy D. Becker
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timothy D. Becker has a total of 124 co-authors. Here are the top co-authors by number of shared publications:
- Timothy Rice
Icahn School of Medicine at Mount Sinai
7 shared publications - Ari Ho-Foster
University of Botswana
6 shared publications - Sean Lynch
Department of Psychiatry Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, Mount Sinai Behavioral Health Center New York New York USA
6 shared publications - Lawrence Hsin Yang
School of Nursing, Duke University, Durham, USA
5 shared publications Alicia Leong
Icahn School of Medicine at Mount Sinai
4 shared publicationsDalton Martin
Icahn School of Medicine at Mount Sinai
4 shared publications
Latest Publications
- Open Access
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-26
MIND: Empowering Mental Health Clinicians with Multimodal Data Insights through a Narrative Dashboard
- 13 April 2026
- Published by Association for Computing Machinery (ACM)
- p. 1-26
Open AccessMIND: Empowering Mental Health Clinicians with Multimodal Data Insights through a Narrative Dashboard
- 27 January 2026
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 31 (3) , 1067-1084
Beyond the Bed: What Clinical and Non-clinical Factors Drive Length of Stay in Pediatric Psychiatry?
Background: Rates of psychiatric disorders and related hospitalizations among youth in the United States have risen substantially over recent decades. Despite evidence supporting outpatient care, fewer than half of youth receive treatment. When outpatient management is insufficient, inpatient psychiatric hospitalization is required, though it is costly, disruptive, and limited in availability. Prior research on predictors of inpatient length of stay has been dated and heterogenous, highlighting the need to identify current clinical and non-clinical factors associated with prolonged stays among youth populations. Method: This IRB-approved retrospective study reviewed the medical records of 1,101 child and adolescent patients admitted to an inpatient psychiatric unit between June 1, 2018, and November 30, 2021. Baseline sociodemographic and clinical data were collected, and LOS was categorized into three groups: below-average (0–6 days), average (7–14 days), and above-average (15+ days). Comparative statistics were performed, and linear regression was used to identify independent predictors of LOS. Results: The average LOS was 10.5 days. Significant predictors of prolonged LOS included public insurance, admission for psychosis or suicide attempt, involvement of child protective services, number of prior hospitalizations, and number of medications prior to admission. Conclusion: Prolonged LOS in psychiatrically hospitalized youth is associated with specific clinical and non-clinical factors. Identifying these predictors at admission can guide treatment planning and set realistic expectations for families. Further research is required to validate these findings and explore the impact of LOS on treatment outcomes.
- 27 January 2026
- Published by SAGE Publications in Clinical Child Psychology and Psychiatry
- Vol. 31 (3) , 1067-1084
Beyond the Bed: What Clinical and Non-clinical Factors Drive Length of Stay in Pediatric Psychiatry?
Background: Rates of psychiatric disorders and related hospitalizations among youth in the United States have risen substantially over recent decades. Despite evidence supporting outpatient care, fewer than half of youth receive treatment. When outpatient management is insufficient, inpatient psychiatric hospitalization is required, though it is costly, disruptive, and limited in availability. Prior research on predictors of inpatient length of stay has been dated and heterogenous, highlighting the need to identify current clinical and non-clinical factors associated with prolonged stays among youth populations. Method: This IRB-approved retrospective study reviewed the medical records of 1,101 child and adolescent patients admitted to an inpatient psychiatric unit between June 1, 2018, and November 30, 2021. Baseline sociodemographic and clinical data were collected, and LOS was categorized into three groups: below-average (0–6 days), average (7–14 days), and above-average (15+ days). Comparative statistics were performed, and linear regression was used to identify independent predictors of LOS. Results: The average LOS was 10.5 days. Significant predictors of prolonged LOS included public insurance, admission for psychosis or suicide attempt, involvement of child protective services, number of prior hospitalizations, and number of medications prior to admission. Conclusion: Prolonged LOS in psychiatrically hospitalized youth is associated with specific clinical and non-clinical factors. Identifying these predictors at admission can guide treatment planning and set realistic expectations for families. Further research is required to validate these findings and explore the impact of LOS on treatment outcomes.
- 29 July 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (5) , 108000
Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York
- 29 July 2025
- Published by Elsevier in American Journal of Preventive Medicine
- Vol. 69 (5) , 108000
Labeling of Cannabis Products From Licensed and Unlicensed Retailers in New York
- 22 July 2025
- Published by Taylor & Francis in The Psychoanalytic Study of the Child
- Vol. 79 (1) , 224-242
Adolescent Vaping: Revisiting Developmental Perspectives on Adolescent Substance Use in the Digital Age
Every wave of preferred substance use in adolescence serves similar developmental functions. The recent explosion among adolescents of electronic nicotine delivery systems (ENDS), popularly known as vaping, offers an opportunity to revisit models of the role of substance use in adolescent development. Social media's rise alongside that of ENDS distinguishes this recent phenomenon from previous historical waves of substance abuse: Vaping was and remains highly integrated into the digital culture, situating social media as a unique window into the adolescent users' subjective experience. To that end, we employ analyses of vaping manifestations within adolescent social media to complement clinical case material. We position adolescent vaping as an action-oriented facilitation of externalization, individuation, and challenge to authority that can precipitate adolescent-adult enactments. We propose that this use-reinforcing developmental function complements other biological and social properties of ENDS to cement its position within contemporary adolescent culture. We suggest that the evolution of adolescents' preferred devices from pens to USB-like devices to round pastel Elf Bar types and new wave cannabis products is driven by this trend's successive approximation to satisfaction of an adolescent developmental demand. While legal and limit-setting efforts to reduce adolescent vaping have been partially successful, we offer this updated developmental model to complement existing public health efforts in reducing adolescent ENDS use through an understanding and integration of its developmental meanings.
- 22 July 2025
- Published by Taylor & Francis in The Psychoanalytic Study of the Child
- Vol. 79 (1) , 224-242
Adolescent Vaping: Revisiting Developmental Perspectives on Adolescent Substance Use in the Digital Age
Every wave of preferred substance use in adolescence serves similar developmental functions. The recent explosion among adolescents of electronic nicotine delivery systems (ENDS), popularly known as vaping, offers an opportunity to revisit models of the role of substance use in adolescent development. Social media's rise alongside that of ENDS distinguishes this recent phenomenon from previous historical waves of substance abuse: Vaping was and remains highly integrated into the digital culture, situating social media as a unique window into the adolescent users' subjective experience. To that end, we employ analyses of vaping manifestations within adolescent social media to complement clinical case material. We position adolescent vaping as an action-oriented facilitation of externalization, individuation, and challenge to authority that can precipitate adolescent-adult enactments. We propose that this use-reinforcing developmental function complements other biological and social properties of ENDS to cement its position within contemporary adolescent culture. We suggest that the evolution of adolescents' preferred devices from pens to USB-like devices to round pastel Elf Bar types and new wave cannabis products is driven by this trend's successive approximation to satisfaction of an adolescent developmental demand. While legal and limit-setting efforts to reduce adolescent vaping have been partially successful, we offer this updated developmental model to complement existing public health efforts in reducing adolescent ENDS use through an understanding and integration of its developmental meanings.
- 26 March 2025
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 45 (3) , 243-250
Predictors and Correlates of Psychiatric Polypharmacy Among Child and Adolescent Psychiatric Inpatients
Purpose/Background: Rates of prescriptions of psychotropic medications to youth have increased, a significant proportion of which are recipients of psychiatric polypharmacy. Polypharmacy can increase the risk of multiple negative outcomes. Prior studies attempting to identify predictors/correlates of polypharmacy have been heterogeneous. This study aimed to examine factors associated with polypharmacy among psychiatrically hospitalized youth, and measure changes in polypharmacy over time throughout the COVID-19 pandemic. Methods/Procedures: The medical records of 1101 patients were reviewed. Sociodemographic and clinical information was collected and analyzed using SPSS. Findings/Results: About one-third of patients received psychotropic polypharmacy; this group contained a higher percentage of males, White patients, and fewer Asian/South Asian patients. They had on average more hospitalizations, a longer hospitalization period, and were more likely to be diagnosed with an impulsive/behavioral disorder, developmental disorder, or bipolar spectrum disorder. They were twice as likely to receive medication for agitation while hospitalized. A regression model identified positive predictors of polypharmacy as having a history of violence and a higher number of psychiatric hospitalizations. Negative predictors included non-White race. The rate of polypharmacy was relatively stable throughout the study time period, and no impact of the COVID-19 pandemic was found. Implications/Conclusions: Pediatric psychiatric polypharmacy is relatively common and may be associated with poorer outcomes. Certain sociodemographic and clinical characteristics may aid clinicians in predicting which youth may be at risk for polypharmacy. Longitudinal studies are indicated to examine outcomes of polypharmacy so that providers can effectively implement judicious prescribing practices in the community.
- 26 March 2025
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 45 (3) , 243-250
Predictors and Correlates of Psychiatric Polypharmacy Among Child and Adolescent Psychiatric Inpatients
Purpose/Background: Rates of prescriptions of psychotropic medications to youth have increased, a significant proportion of which are recipients of psychiatric polypharmacy. Polypharmacy can increase the risk of multiple negative outcomes. Prior studies attempting to identify predictors/correlates of polypharmacy have been heterogeneous. This study aimed to examine factors associated with polypharmacy among psychiatrically hospitalized youth, and measure changes in polypharmacy over time throughout the COVID-19 pandemic. Methods/Procedures: The medical records of 1101 patients were reviewed. Sociodemographic and clinical information was collected and analyzed using SPSS. Findings/Results: About one-third of patients received psychotropic polypharmacy; this group contained a higher percentage of males, White patients, and fewer Asian/South Asian patients. They had on average more hospitalizations, a longer hospitalization period, and were more likely to be diagnosed with an impulsive/behavioral disorder, developmental disorder, or bipolar spectrum disorder. They were twice as likely to receive medication for agitation while hospitalized. A regression model identified positive predictors of polypharmacy as having a history of violence and a higher number of psychiatric hospitalizations. Negative predictors included non-White race. The rate of polypharmacy was relatively stable throughout the study time period, and no impact of the COVID-19 pandemic was found. Implications/Conclusions: Pediatric psychiatric polypharmacy is relatively common and may be associated with poorer outcomes. Certain sociodemographic and clinical characteristics may aid clinicians in predicting which youth may be at risk for polypharmacy. Longitudinal studies are indicated to examine outcomes of polypharmacy so that providers can effectively implement judicious prescribing practices in the community.
- 7 November 2024
- Published by Elsevier in Child Abuse & Neglect
- Vol. 158, 107134
Psychiatric crises among youth with a history of trauma during COVID-19: A retrospective study of psychiatrically hospitalized children and adolescents
- 7 November 2024
- Published by Elsevier in Child Abuse & Neglect
- Vol. 158, 107134
Psychiatric crises among youth with a history of trauma during COVID-19: A retrospective study of psychiatrically hospitalized children and adolescents
- 1 February 2024
- Published by Edizioni Minerva Medica in Minerva Pediatrics
- Vol. 76 (1) , 108-118
A clinical overview of adolescent e-cigarette use (vaping)
Article: A clinical overview of adolescent e-cigarette use (vaping) - Minerva Pediatrics 2023 Jul 10 - Minerva Medica - Journals
- 1 February 2024
- Published by Edizioni Minerva Medica in Minerva Pediatrics
- Vol. 76 (1) , 108-118
A clinical overview of adolescent e-cigarette use (vaping)
Article: A clinical overview of adolescent e-cigarette use (vaping) - Minerva Pediatrics 2023 Jul 10 - Minerva Medica - Journals
- 29 December 2023
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 45 (1) , 33-43
Predictors and Correlates of Positive Urine Drug Screening in a Retrospective Cohort Analysis of Child and Adolescent Psychiatry Inpatients Throughout the COVID-19 Pandemic
Background and Objectives: Youth substance use is associated with significant psychological, neurological, and medical complications. Risk factors for substance use among children and adolescents in the general population include peer and/or parental substance use, certain psychiatric illnesses (eg, Attention-Deficit/Hyperactivity Disorder, depression), and history of maltreatment. Co-occurring substance use and psychiatric illness have been associated with increased suicidality, but few prior studies have characterized substance use among child/adolescent inpatients. As such, it remains unclear how substance use contributing to acute psychiatric presentations has changed since the start of the COVID-19 pandemic. Methods: This is a retrospective cohort study of 816 unique child/adolescent psychiatry inpatients with urine drug screening (UDS) results from a diverse urban setting. Charts of patients hospitalized between June 1, 2018 and November 30, 2021 were reviewed for sociodemographic characteristics, indication for admission, psychiatric history, hospital course, treatment plan, and discharge diagnosis. Differences in sociodemographic and clinical characteristics, such as age, race, and diagnoses, between patients with and without positive UDS were explored throughout various periods of the COVID-19 pandemic. Descriptive and comparative statistics were performed, as well as a logistic regression model to identify the predictors of positive UDS. Results: Of the study sample, 18% had a positive UDS. Older age, diagnosis of impulsive or behavioral disorder, and a history of violence were found to be predictors of positive UDS. Asian/South Asian or Hispanic/LatinX race and history of a developmental or intellectual disability were found to be negative predictors. The frequency of positive UDS in this population did not change based on COVID-19. Discussion and Conclusions: Multiple factors may predispose children and adolescents to substance use. Though no impact of COVID-19 was found in this sample, longer-term studies are needed. Scientific Significance: This study identifies independent predictors of active substance use in the child and adolescent psychiatric inpatient population.
- 29 December 2023
- Published by SAGE Publications in Substance use & addiction journal
- Vol. 45 (1) , 33-43
Predictors and Correlates of Positive Urine Drug Screening in a Retrospective Cohort Analysis of Child and Adolescent Psychiatry Inpatients Throughout the COVID-19 Pandemic
Background and Objectives: Youth substance use is associated with significant psychological, neurological, and medical complications. Risk factors for substance use among children and adolescents in the general population include peer and/or parental substance use, certain psychiatric illnesses (eg, Attention-Deficit/Hyperactivity Disorder, depression), and history of maltreatment. Co-occurring substance use and psychiatric illness have been associated with increased suicidality, but few prior studies have characterized substance use among child/adolescent inpatients. As such, it remains unclear how substance use contributing to acute psychiatric presentations has changed since the start of the COVID-19 pandemic. Methods: This is a retrospective cohort study of 816 unique child/adolescent psychiatry inpatients with urine drug screening (UDS) results from a diverse urban setting. Charts of patients hospitalized between June 1, 2018 and November 30, 2021 were reviewed for sociodemographic characteristics, indication for admission, psychiatric history, hospital course, treatment plan, and discharge diagnosis. Differences in sociodemographic and clinical characteristics, such as age, race, and diagnoses, between patients with and without positive UDS were explored throughout various periods of the COVID-19 pandemic. Descriptive and comparative statistics were performed, as well as a logistic regression model to identify the predictors of positive UDS. Results: Of the study sample, 18% had a positive UDS. Older age, diagnosis of impulsive or behavioral disorder, and a history of violence were found to be predictors of positive UDS. Asian/South Asian or Hispanic/LatinX race and history of a developmental or intellectual disability were found to be negative predictors. The frequency of positive UDS in this population did not change based on COVID-19. Discussion and Conclusions: Multiple factors may predispose children and adolescents to substance use. Though no impact of COVID-19 was found in this sample, longer-term studies are needed. Scientific Significance: This study identifies independent predictors of active substance use in the child and adolescent psychiatric inpatient population.